In keeping with the cellular dogma of TB vaccine design, it is m-EsxI, which induces the greatest CD8+ T cell response of any single antigen vaccine and a strong CD4+ T cell response, that is the only single construct to achieve statistically significant protection against in vivo Mtb infection, albeit in only one of the two relevant infection studies. The gene discussed is CD8A; the disease is tuberculosis.